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INTRODUCTION:  The  thyroid  gland  is  a rare  site of  clinically  detectable  tumor  metastasis.  As  thyroid
tumors  are usually  assumed  to be primary  in origin,  its  recognition  as a secondary  is difﬁcult.
PRESENTATION  OF  CASE:  We report  a case  of  an 80-year  old  female  who  was  referred  to  the  Department  of
Surgery  for  a symptomatic  thyroid  nodule.  Her  medical  history  included  a radical  nephrectomy  for  renal
cell  carcinoma  (RCC)  nine  years  ago.  During  follow-up  a pancreatic  nodule  was  noted  suggestive  of  a  neu-
roendocrine  tumor  and  the  von  Hippel-Lindau  syndrome  had to  be ruled  out.  The  ﬁne-needle  aspiration
biopsy  (FNAB)  guided  by ultrasound  (US)  of  the thyroid  nodule  was  inconclusive  and  a  hemithyroidec-
tomy  and  isthmectomy  were  performed.  Histological  examination  revealed  metastasis  of a clear  cell
carcinoma.
DISCUSSION:  RCC  disseminates  in  an  unpredictable  manner  and  can show  late recurrences.  Although
secondary  involvement  of the  thyroid  gland  by  RCC  is rare,  it is  still one  of the  more  common  neoplasms  to
metastasize  to this  site. There  are  no speciﬁc  clinical  features  and  few characteristic  ﬁndings  of  metastatic
thyroid  carcinoma  on imaging  studies.  FNAB  is  a  useful  procedure  to  diagnose  metastatic  thyroid  cancer,
but  one  should  remain  suspicious  when  the  result  for malignant  cells  is negative  or  indeterminate.  After
thyroidectomy  the  diagnosis  of  RCC  is  conﬁrmed  immunohistochemically.  There  is  a clear  survival  beneﬁt
if  a surgical  approach  to  the  thyroid  metastasis  is  chosen.
CONCLUSION:  Thyroid  metastasis  should  be considered  in patients  with  a thyroid  nodule  and  positive
history  for RCC.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
The thyroid gland is a rare site of clinically detectable tumor
etastasis [1–4]. As thyroid tumors are usually assumed to be
rimary in origin, the distinction from a secondary is a clinical
hallenge [1,5–8].
The case report presented below was written according to the
ARE guidelines [9].
. Presentation of case
An 80-year-old white woman was referred to the Department of
urgery for a symptomatic thyroid nodule (Fig. 1). The nodule had
een diagnosed four years earlier by US, which revealed a solid and
ell deﬁned heterogeneous formation in the right hemithyroid,
easuring 33 × 21 mm,  containing an area of cystic degeneration.
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The patient was asymptomatic at that time, with a euthyroid sta-
tus. FNAB guided by US of the thyroid nodule was performed and
the cytological examination was inconclusive. Given the age of the
patient, comorbidities and her asymptomatic status, surveillance
was decided.
Her medical history included hypertension, dyslipidemia, obe-
sity, paroxysmal atrial ﬁbrillation, pulmonary tuberculosis, chronic
thrombocytopenia and RCC nine years ago, treated by a radi-
cal nephrectomy. The tumor removed was  5 cm in size; it was
located in the upper pole of the right kidney and a clear cell car-
cinoma was  reported, of Fuhrman nuclear grade 2. The patient’s
postoperative course and subsequent recovery were uneventful.
Neither postoperative chemotherapy nor interferon was pro-
posed.
During follow-up, a computed tomography (CT) scan revealed a
20 mm  vascularized nodule in the middle portion of the pancreas
body (Fig. 2).
A subsequent magnetic resonance imaging (MRI) identiﬁed a
solid nodule in the transition between the pancreatic body and tail,
measuring 20 × 13 mm,  with an enhancement pattern suggestive
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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sFig. 1. Patient medical history tif a neuroendocrine origin (Fig. 3). An octreotide scintigraphy was
erformed identifying a focus of anomalous hyper-expression of
omatostatin receptors, with increased uptake in the pancreas ande and clinical case presentation.the right lobe of the thyroid. In order to rule out von Hippel-Lindau
syndrome a cerebral MRI  was  done, as well as ophthalmologic eval-
uation, which were normal.
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Fig. 2. Computed tomography image of the nodule in the middle portion of the body of the pancreas.
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dig. 3. Magnetic resonance imaging showing a solid nodule in the transition betw
euroendocrine origin.
In 2012 the patient remained euthyroid but the appearance
f symptoms, such as cervical pain and hoarseness, led to a new
NAB guided by US that once again was inconclusive. Cervical
xamination revealed a nodule in the right lobe of the thyroid,
easuring about 3 × 3 cm.  Due to the symptoms, a hemithyroidec-
omy and isthmectomy was performed. The resection was  carried
ut without difﬁculty after identifying superior and inferior right
arathyroid glands and the right laryngeal recurrent nerve (Fig. 4).
he postoperative course was uneventful. After 11 months, the
atient was doing well and had not developed any additional
etastasis. The follow-up CT-scan showed an increase in the size
f the nodule in the body of the pancreas previously identiﬁed, and
 new one in the head of the pancreas with similar characteristics.
fter the multidisciplinary team discussion no further investigation
r treatment was proposed due to patient’s age and comorbidities..1. Pathologic ﬁndings
The resected specimen weighed 26.7 g and revealed a well-
eﬁned yellowish nodule, with cystic areas, measuring 2.7 × 2.5 cm,dy and tail of the pancreas (arrow), with an enhancement pattern suggestive of a
was identiﬁed. Histological examination (Fig. 5) showed a clear
cell carcinoma immunoreactive for vimentin and CD10, and neg-
ative for thyroglobulin, thyroid transcription factor-1 (TTF-1) and
chromogranin, conﬁrming the renal origin of the tumor.
3. Discussion
RCC disseminates in an unpredictable manner and can show late
recurrences [3,5,10–13]. Although secondary involvement of the
thyroid gland by RCC is rare, it is still one of the more common
neoplasms to metastasize to this site. A thyroid mass can be the
ﬁrst clinical manifestation of RCC, even masquerading as a primary
thyroid gland neoplasm [6,11,12,14–16].
Despite the rich blood supply of the thyroid, it is a rare site of
metastasis, which accounts for approximately 2% of thyroid malig-
nancies [3,16,17]. Autopsy studies demonstrate a higher prevalence
[2,6,18], with thyroid involvement in up to 24% of cases show-
ing widespread malignant disease [2–4,7,11–13,15–17,19]. Most
of the patients with metastatic thyroid tumor are asymptomatic at
presentation [2,17]. There are no speciﬁc clinical features and few
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Fig. 4. Dislocation of the right lobe of the thyroid with exposure of the right recur-
rent  laryngeal nerve and the right inferior parathyroid.
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Urol. Assoc. J. 6 (5) (2012) E209–12.ig. 5. Well-demarcated nodule of metastatic RCC in the thyroid. Inset: tumor cells
ith clear cytoplasm and hypercromatic nuclei.
haracteristic ﬁndings of metastatic thyroid carcinoma on imaging
tudies such as US and CT [2,3,8,13,17]. The use of preoperative
NAB, with low morbidity and reasonable cost, has been empha-
ized as an effective and useful procedure for the diagnosis of
etastatic thyroid cancer [2,4,17]. Contrary to the wide consen-
us that FNAB is an accurate diagnostic tool, Chung et al. reviewing
he literature of metastasis reported a high false negative rate of
8.7% [15]. Thus, one should remain suspicious for metastatic dis-
ase to the thyroid gland when FNAB is negative or indeterminate
or malignant cells [15].
After thyroidectomy, the diagnosis of RCC was conﬁrmed by
he positive immunohistochemical result for CD10 and vimentin
3,14,17] and negative for thyroglobulin, calcitonin and TTF-1 [3].
here is a clear survival beneﬁt in surgical resection of the thyroid
etastasis is chosen, with a mean 5-year survival rate of 30–60%
[
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[20]. However in general patients have a poor prognosis, since
the presence of a thyroid metastasis is often the expression of
widespread systemic disease [2,4,5,14,15,17].
The possibility of von Hippel-Lindau disease (VHLD), an auto-
somal dominant syndrome characterized by the presence of
multiple cysts and tumors was  considered. The clinical presen-
tation may  be quite variable and the most common lesions
include central nervous system or retinal hemangioblastoma, RCC,
pheochromocytoma, pancreatic cysts or endocrine tumor, epididy-
mal  cystoadenoma or endolymphatic sac tumor [21]. In the present
case, the diagnosis of pancreatic lesions suggesting a neuroen-
docrine nature in a patient with history of RCC motivated the
investigation of other typical manifestations of VHLD. The diag-
nosis of VHLD in patients without family history of this syndrome,
requires at least two hemangioblastomas of the central nervous
system and/or the retina, or alternatively one hemangioblastoma
of the central nervous system or of the retina associated with one
visceral lesion [21]. Hemangioblastomas were not detected in this
case. The age of presentation was  not typical, nor were the clinical
ﬁndings sufﬁcient to warrant further investigation.
4. Conclusion
Preoperative distinction between primary and secondary thy-
roid tumors is difﬁcult. Thyroid metastasis should be considered
in patients with a thyroid nodule and positive history for RCC
[6,11,12,14,15,17]. Immunohistochemistry is essential for conﬁrm-
ing the diagnosis [3,14,17]. The appearance of metastatic disease in
the thyroid gland often indicates poor prognosis, because it indi-
cates advanced disease. On the other hand, there are several reports
suggesting that aggressive treatment for solitary thyroid metastasis
may  prolong survival [2,4,5,14,15,17].
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